Validation Study for Endometriosis PRO

ClinicalTrials.gov ID: NCT01643122

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT01643122. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 12, 2026, 9:57 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Validation Study to Assess Psychometric Properties of a Newly Developed Patient Reported Outcome Tool for Endometriosis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Assess the psychometric properties of the Endometriosis Symptom Diary (ESD) and the Endometriosis Impact Scale (EIS) and provide evidence whether the PRO measures are reliable, valid and able to detect changes over time in approximately 250 patients with mild, moderate or severe endometriosis confirmed by laparoscopy.

Study identification

NCT ID: NCT01643122
Recruitment status: Completed
Study type: Observational
Phase: Not listed
Lead sponsor: Bayer; Industry
Enrollment: 275 participants

Conditions and interventions

Conditions

Endometriosis

Interventions

No drug Other

Other

Eligibility (public fields only)

Age range: 18 Years to 45 Years
Sex: Female
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Aug 2012 (Type not available)
Primary completion: Jul 2013 (Actual)
Completion: Sep 2013 (Actual)
Last update posted: Oct 13, 2014

2012 – 2013

United States locations

U.S. sites: 20
U.S. states: 16
U.S. cities: 19

Facility	City	State	ZIP	Site status
Not listed	Jonesboro	Arkansas	72401	—
Not listed	Sacramento	California	95816	—
Not listed	San Diego	California	92103	—
Not listed	San Diego	California	92108	—
Not listed	San Francisco	California	94102	—
Not listed	New Haven	Connecticut	06511	—
Not listed	Decatur	Georgia	30034	—
Not listed	Champaign	Illinois	61820	—
Not listed	Worcester	Massachusetts	01655	—
Not listed	Rochester	Minnesota	55905	—
Not listed	Brooklyn	New York	11203	—
Not listed	Greensboro	North Carolina	27408	—
Not listed	Cincinnati	Ohio	45242	—
Not listed	Portland	Oregon	97239	—
Not listed	Philadelphia	Pennsylvania	19104	—
Not listed	San Angelo	Texas	76904	—
Not listed	Salt Lake City	Utah	84107	—
Not listed	Sandy City	Utah	84070	—
Not listed	Norfolk	Virginia	23502	—
Not listed	Seattle	Washington	98105	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT01643122, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Oct 13, 2014 · Synced Nov 12, 2026